TNXA
Putative tenascin-XA
Also known as: TENXA_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for TNXA in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
311 residues, UniProt reviewed canonical sequence.
>Q16473|TNXA
1 MEDKNGAPHG APHSDSPLGF SHAAPEEDTP APELAPEAPE PPEEPRLGVL TVTDTTPDSM
61 RLSWSVAQGP FDSFVVQYED TNGQPQALLV DGDQSKILIS GLEPSTPYRF LLYGLHEGKR
121 LGPLSAEGTT GLAPAGQTSE ESRPRLSQLS VTDVTTSSLR LNWEAPPGAF DSFLLRFGVP
181 SPSTLEPHPR PLLQRELMVP GTRHSAVLRD LRSGTLYSLT LYGLRGPHKA DSIQGTARTL
241 SPVLESPRDL QFSEIRETSA KVNWMPPPSR ADSFKVSYQL ADGGEPQSVQ VDGRARTQKL
301 QFLTVPHSCV HLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNXA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNXA as an antibody target. Whether an autoantibody or antibody against TNXA could matter depends on whether native TNXA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNXA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TNXA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...